K. Scott Phillips,
Biofilms Research Group Leader
Kenneth “Scott” Phillips is Biofilms Research Group Leader in the FDA Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Division of Biology, Chemistry and Materials Science (DBCMS), at the White Oak Federal Research Center. He did PhD research in Analytical Chemistry at the University of California, Riverside, and an NIH Postdoctoral Fellowship in Chemistry/Biomedical Engineering at the University of North Carolina, Chapel Hill. He has over 30 publications in analytical chemistry and biomaterials. Some of his most significant research achievements are the development of the first heterogeneous microfluidic immunoassay, work on patterned nanoglassified surface plasmon resonance (SPR) substrates, and the development of the first continuous single cell analysis-on-a-chip based on laser lysis and electrophoresis. Dr. Phillips has been researching medical device associated infections at the FDA for over 6 years now, performs about 40 consults per year to assist with regulatory review of medical devices, and is involved in a number of regulatory science efforts in CDRH.
|
|
|
